Study of Treatment of Thoracic Aortic Aneurysms and Dilatation in Combination With Tricuspid and Bicuspid Aortic Valves.

Clinical Study of Diagnosis and Treatment of Thoracic Aortic Aneurysms and Dilatation in Combination With Tricuspid and Bicuspid Aortic Valves.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04372563

Enrollment

Registered

2020-05-04

Start date

2020-01-24

Completion date

2026-01-24

Last updated

2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ascending Aorta Aneurysm, Dilation of the Ascending Aorta

Brief summary

Clarification of indications for surgical correction in patients with borderline expansion of the ascending aorta

Detailed description

Expanding indications for surgical treatment of patients with borderline values of the ascending aorta

Interventions

OTHERaortic prosthetics

aortic prosthetics

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

45 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

1. Extension of the ascending aorta less than 55 mm 2. Tricuspid Aortic Valves. 3. Extension of the ascending aorta more than 45 mm

Exclusion criteria

1. Age less 45 years 2. Age more 75 years 3. Multiple organ failure 4. oncological disease

Design outcomes

Primary

Measure	Time frame	Description
death	30 day after operation	death
aorto-associated complications	30 day	rupture, dissection

Secondary

Measure	Time frame	Description
increasing the diameter of the ascending aorta	1 year	increasing the diameter of the ascending aorta more than 55 mm

Countries

Russia

Contacts

Primary ContactBoris N Kozlov, MD

hospital@cardio-tomsk.ru3822558122

Backup ContactBoris N Kozlov, MD

eva00@list.ru89069541331

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026